The pathogenesis of Ebola hemorrhagic fever

Trends in Microbiology

Volumn 9, Issue 10, 2001, Pages 506-511

  Takada, Ayato ^a   Kawaoka, Yoshihiro ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; NEUTRALIZING ANTIBODY; PLASMID DNA; UNCLASSIFIED DRUG; VIRULENCE FACTOR; VIRUS ANTIBODY; VIRUS GLYCOPROTEIN; VIRUS PROTEIN 40; VIRUS VACCINE; VIRUS VECTOR;

BLEEDING; CYTOTOXICITY; DISSEMINATED INTRAVASCULAR CLOTTING; EBOLA VIRUS; GENETIC ENGINEERING; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; MACROPHAGE; NONHUMAN; PASSIVE IMMUNIZATION; PASSIVE TRANSPORT; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN DEGRADATION; REVIEW; VIRUS HEMORRHAGIC FEVER; VIRUS INFECTIVITY; VIRUS PATHOGENESIS;

DISSEMINATED INTRAVASCULAR COAGULATION; EBOLAVIRUS; HEMORRHAGE; HEMORRHAGIC FEVER, EBOLA; HUMANS; IMMUNIZATION, PASSIVE; INTERFERONS; MEMBRANE FUSION; NUCLEOPROTEINS; VIRAL CORE PROTEINS; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 0035476472     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-842X(01)02201-6     Document Type: Review

References (62)

1. Filoviridae: Marburg and Ebola viruses
2. Experimental filovirus infection
3. Processing of the Ebola virus glycoprotein
4. A system for functional analysis of Ebola virus glycoprotein
5. Characterization of Ebola virus entry by using pseudotyped viruses: Identification of receptor-deficient cell lines
6. GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases
7. The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing
8. Host cell proteases controlling virus pathogenicity
9. Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease
10. Proprotein-processing endoproteases PC6 and furin both activate hemagglutinin of virulent avian influenza viruses
11. Processing of the Ebola virus glycoprotein by the proprotein convertase furin
12. Endoproteolytic processing of the Ebola virus envelope glycoprotein: Cleavage is not required for function
13. Ebola virus glycoprotein: Proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies
14. Downregulation of β1 integrins by Ebola virus glycoprotein: Implication for virus entry
15. Replication of Marburg virus in human endothelial cells. A possible mechanism for the development of viral hemorrhagic disease
16. Pathology of experimental Ebola virus infection in African green monkeys. Involvement of fibroblastic reticular cells
17. Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins
18. Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury
19. Differential induction of cellular detachment by envelope glycoproteins of Marburg and Ebola (Zaire) viruses
20. Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates
21. Ebola virus secretory glycoprotein (sGP) diminishes FcγRIIIB-to-CR3 proximity on neutrophils
22. Ebola virus, neutrophils, and antibody specificity
23. Immune response to filovirus infections
24. Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity
25. Molecular pathogenesis of filovirus infections: Role of macrophages and endothelial cells
26. Cytoplasmic assembly and accumulation of human immunodeficiency virus types 1 and 2 in recombinant human colony-stimulating factor-1-treated human monocytes: An ultrastructural study
27. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients
28. Pathophysiology of shock and hemorrhage in a fulminating viral infection (Ebola)
29. An analysis of features of pathogenesis in two animal models of Ebola virus infection
30. Pathologic features of Filovirus infections in humans
31. Markedly elevated levels of interferon (IFN)-γ, IFN-α, interleukin (IL)-2, IL-10, and tumor necrosis factor-α associated with fatal Ebola virus infection
32. Human asymptomatic Ebola infection and strong inflammatory response
33. The Ebola virus VP35 protein functions as a type I IFN antagonist
34. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems
35. The envelope glycoprotein of Ebola virus contains an immunosuppressive-like domain similar to oncogenic retroviruses
36. Suppressive effect of Ebola virus on T cell proliferation in vitro is provided by 125-kDa GP viral protein
37. Ebola virus inhibits induction of genes by double-stranded RNA in endothelial cells
38. Ebola virus selectively inhibits responses to interferons, but not to interleukin-1β, in endothelial cells
39. The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus
40. Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses
41. Folate receptor-α is a cofactor for cellular entry by Marburg and Ebola viruses
42. Ebola virus VP40-induced particle formation and association with the lipid bilayer
43. A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: Implications for filovirus budding
44. Ubiquitin and the control of protein fate in the secretory and endocytic pathways
45. Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses
46. Evaluation of immune globulin and recombinant interferon-α2β for treatment of experimental Ebola virus infections
47. Preparation and use of hyperimmune serum for prophylaxis and therapy of Ebola virus infections
48. Filovirus diseases
49. Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients
50. Passive transfer of antibodies protect immunocompetent and immunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication
51. Epitopes involved in antibody-mediated protection from Ebola virus
52. Infectivity-enhancing antibodies to Ebola virus glycoprotein
53. DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge
54. Immunization for Ebola virus infection
55. Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus
56. Development of a preventive vaccine for Ebola virus infection in primates
57. Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein
58. Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems
59. A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever
60. Animal pathology of filovirus infections
61. The nonstructural small glycoprotein sGP of Ebola virus is secreted as an antiparallel-orientated homodimer
62. Biochemical analysis of the secreted and virion glycoproteins of Ebola virus